

The global Genome Annotation Service market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
The “Genome Annotation Service Industry Forecast” looks at past sales and reviews total world Genome Annotation Service sales in 2022, providing a comprehensive analysis by region and market sector of projected Genome Annotation Service sales for 2023 through 2029. With Genome Annotation Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genome Annotation Service industry.
This Insight Report provides a comprehensive analysis of the global Genome Annotation Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Genome Annotation Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genome Annotation Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genome Annotation Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genome Annotation Service.
United States market for Genome Annotation Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Genome Annotation Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Genome Annotation Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Genome Annotation Service players cover Charles River, Lexogen, Eurofins Scientific, Natera, BGI, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Genome Annotation Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
RAST Tool Kit
Viral Genome ORF Reader
Segmentation by Application:
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
RAST Tool Kit
Viral Genome ORF Reader
Segmentation by Application:
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Charles River
Lexogen
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Personalis
Novogene
Genotypic Technology
Dna Link
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Genome Annotation Service Market Size 2019-2030
2.1.2 Genome Annotation Service Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Genome Annotation Service by Country/Region, 2019, 2023 & 2030
2.2 Genome Annotation Service Segment by Type
2.2.1 RAST Tool Kit
2.2.2 Viral Genome ORF Reader
2.3 Genome Annotation Service Market Size by Type
2.3.1 Genome Annotation Service Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Genome Annotation Service Market Size Market Share by Type (2019-2024)
2.4 Genome Annotation Service Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Biopharma Companies
2.4.3 Academic & Research Organizations
2.4.4 Others
2.5 Genome Annotation Service Market Size by Application
2.5.1 Genome Annotation Service Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Genome Annotation Service Market Size Market Share by Application (2019-2024)
3 Genome Annotation Service Market Size by Player
3.1 Genome Annotation Service Market Size Market Share by Player
3.1.1 Global Genome Annotation Service Revenue by Player (2019-2024)
3.1.2 Global Genome Annotation Service Revenue Market Share by Player (2019-2024)
3.2 Global Genome Annotation Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Genome Annotation Service by Region
4.1 Genome Annotation Service Market Size by Region (2019-2024)
4.2 Global Genome Annotation Service Annual Revenue by Country/Region (2019-2024)
4.3 Americas Genome Annotation Service Market Size Growth (2019-2024)
4.4 APAC Genome Annotation Service Market Size Growth (2019-2024)
4.5 Europe Genome Annotation Service Market Size Growth (2019-2024)
4.6 Middle East & Africa Genome Annotation Service Market Size Growth (2019-2024)
5 Americas
5.1 Americas Genome Annotation Service Market Size by Country (2019-2024)
5.2 Americas Genome Annotation Service Market Size by Type (2019-2024)
5.3 Americas Genome Annotation Service Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Genome Annotation Service Market Size by Region (2019-2024)
6.2 APAC Genome Annotation Service Market Size by Type (2019-2024)
6.3 APAC Genome Annotation Service Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Genome Annotation Service Market Size by Country (2019-2024)
7.2 Europe Genome Annotation Service Market Size by Type (2019-2024)
7.3 Europe Genome Annotation Service Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Genome Annotation Service by Region (2019-2024)
8.2 Middle East & Africa Genome Annotation Service Market Size by Type (2019-2024)
8.3 Middle East & Africa Genome Annotation Service Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Genome Annotation Service Market Forecast
10.1 Global Genome Annotation Service Forecast by Region (2025-2030)
10.1.1 Global Genome Annotation Service Forecast by Region (2025-2030)
10.1.2 Americas Genome Annotation Service Forecast
10.1.3 APAC Genome Annotation Service Forecast
10.1.4 Europe Genome Annotation Service Forecast
10.1.5 Middle East & Africa Genome Annotation Service Forecast
10.2 Americas Genome Annotation Service Forecast by Country (2025-2030)
10.2.1 United States Market Genome Annotation Service Forecast
10.2.2 Canada Market Genome Annotation Service Forecast
10.2.3 Mexico Market Genome Annotation Service Forecast
10.2.4 Brazil Market Genome Annotation Service Forecast
10.3 APAC Genome Annotation Service Forecast by Region (2025-2030)
10.3.1 China Genome Annotation Service Market Forecast
10.3.2 Japan Market Genome Annotation Service Forecast
10.3.3 Korea Market Genome Annotation Service Forecast
10.3.4 Southeast Asia Market Genome Annotation Service Forecast
10.3.5 India Market Genome Annotation Service Forecast
10.3.6 Australia Market Genome Annotation Service Forecast
10.4 Europe Genome Annotation Service Forecast by Country (2025-2030)
10.4.1 Germany Market Genome Annotation Service Forecast
10.4.2 France Market Genome Annotation Service Forecast
10.4.3 UK Market Genome Annotation Service Forecast
10.4.4 Italy Market Genome Annotation Service Forecast
10.4.5 Russia Market Genome Annotation Service Forecast
10.5 Middle East & Africa Genome Annotation Service Forecast by Region (2025-2030)
10.5.1 Egypt Market Genome Annotation Service Forecast
10.5.2 South Africa Market Genome Annotation Service Forecast
10.5.3 Israel Market Genome Annotation Service Forecast
10.5.4 Turkey Market Genome Annotation Service Forecast
10.6 Global Genome Annotation Service Forecast by Type (2025-2030)
10.7 Global Genome Annotation Service Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Genome Annotation Service Forecast
11 Key Players Analysis
11.1 Charles River
11.1.1 Charles River Company Information
11.1.2 Charles River Genome Annotation Service Product Offered
11.1.3 Charles River Genome Annotation Service Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Charles River Main Business Overview
11.1.5 Charles River Latest Developments
11.2 Lexogen
11.2.1 Lexogen Company Information
11.2.2 Lexogen Genome Annotation Service Product Offered
11.2.3 Lexogen Genome Annotation Service Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Lexogen Main Business Overview
11.2.5 Lexogen Latest Developments
11.3 Eurofins Scientific
11.3.1 Eurofins Scientific Company Information
11.3.2 Eurofins Scientific Genome Annotation Service Product Offered
11.3.3 Eurofins Scientific Genome Annotation Service Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Eurofins Scientific Main Business Overview
11.3.5 Eurofins Scientific Latest Developments
11.4 Natera
11.4.1 Natera Company Information
11.4.2 Natera Genome Annotation Service Product Offered
11.4.3 Natera Genome Annotation Service Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Natera Main Business Overview
11.4.5 Natera Latest Developments
11.5 BGI
11.5.1 BGI Company Information
11.5.2 BGI Genome Annotation Service Product Offered
11.5.3 BGI Genome Annotation Service Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 BGI Main Business Overview
11.5.5 BGI Latest Developments
11.6 Illumina
11.6.1 Illumina Company Information
11.6.2 Illumina Genome Annotation Service Product Offered
11.6.3 Illumina Genome Annotation Service Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Illumina Main Business Overview
11.6.5 Illumina Latest Developments
11.7 Roche
11.7.1 Roche Company Information
11.7.2 Roche Genome Annotation Service Product Offered
11.7.3 Roche Genome Annotation Service Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Roche Main Business Overview
11.7.5 Roche Latest Developments
11.8 LabCorp
11.8.1 LabCorp Company Information
11.8.2 LabCorp Genome Annotation Service Product Offered
11.8.3 LabCorp Genome Annotation Service Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 LabCorp Main Business Overview
11.8.5 LabCorp Latest Developments
11.9 Berry Genomics
11.9.1 Berry Genomics Company Information
11.9.2 Berry Genomics Genome Annotation Service Product Offered
11.9.3 Berry Genomics Genome Annotation Service Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Berry Genomics Main Business Overview
11.9.5 Berry Genomics Latest Developments
11.10 Brooks Life Sciences
11.10.1 Brooks Life Sciences Company Information
11.10.2 Brooks Life Sciences Genome Annotation Service Product Offered
11.10.3 Brooks Life Sciences Genome Annotation Service Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Brooks Life Sciences Main Business Overview
11.10.5 Brooks Life Sciences Latest Developments
11.11 Macrogen
11.11.1 Macrogen Company Information
11.11.2 Macrogen Genome Annotation Service Product Offered
11.11.3 Macrogen Genome Annotation Service Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Macrogen Main Business Overview
11.11.5 Macrogen Latest Developments
11.12 Personalis
11.12.1 Personalis Company Information
11.12.2 Personalis Genome Annotation Service Product Offered
11.12.3 Personalis Genome Annotation Service Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Personalis Main Business Overview
11.12.5 Personalis Latest Developments
11.13 Novogene
11.13.1 Novogene Company Information
11.13.2 Novogene Genome Annotation Service Product Offered
11.13.3 Novogene Genome Annotation Service Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Novogene Main Business Overview
11.13.5 Novogene Latest Developments
11.14 Genotypic Technology
11.14.1 Genotypic Technology Company Information
11.14.2 Genotypic Technology Genome Annotation Service Product Offered
11.14.3 Genotypic Technology Genome Annotation Service Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Genotypic Technology Main Business Overview
11.14.5 Genotypic Technology Latest Developments
11.15 Dna Link
11.15.1 Dna Link Company Information
11.15.2 Dna Link Genome Annotation Service Product Offered
11.15.3 Dna Link Genome Annotation Service Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Dna Link Main Business Overview
11.15.5 Dna Link Latest Developments
12 Research Findings and Conclusion
*If Applicable.